Evidence map›Paper›PMID 40919250›Full record

ReviewReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2025

Daylight photodynamic therapy in nonmelanoma skin cancers and photorejuvenation.

Paweł Pazdrowski, Oliwia Król, Jan Linkiewicz, Wojciech Lizurej, Marta Moszyńska, Marta Szymoniak-Lipska, Katarzyna Korecka

Abstract readReview
In one paragraph

Review in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Photodynamic Therapy in Dermatology.International journal of molecular sciences · 2026
    Review
  2. Small RNA sequencing of formalin-fixed paraffin embedded human skin biopsies reveals miRNA signatures for actinic keratosis and squamous cell carcinoma.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paweł PazdrowskiClinical Hospital of Poznan University of Medical Sciences, Poznań, Poland.
Oliwia KrólClinical Hospital of Poznan University of Medical Sciences, Poznań, Poland.
Jan LinkiewiczMinistry of Internal Affairs Hospital in Poznan, Poznań, Poland.
Wojciech LizurejClinical Hospital of Poznan University of Medical Sciences, Poznań, Poland.
Marta MoszyńskaClinical Hospital of Poznan University of Medical Sciences, Poznań, Poland.
Marta Szymoniak-LipskaDepartment of Dermatology and Venereology, Poznan University of Medical Sciences, Poznań, Poland.
Katarzyna KoreckaDepartment of Dermatology and Venereology, Poznan University of Medical Sciences, Poznań, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, photodynamic therapy (PDT) is widely used, mainly in treatment of actinic keratosis (AK), especially grades I and II following the Olsen classification. The main side effects include burning, stinging, and pain during irradiation. Alternative protocols include daylight PDT (dPDT), which uses sunlight instead of artificial light after applying a photosensitizer. Unlike conventional PDT, daylight therapy is less painful and more comfortable for patients. This article presents the mechanism of dPDT, indications for this method as well as its efficiency, side effects, advantages and disadvantages. In the end, current treatment protocols of dPDT are presented.

Indexed as

actinic keratosisdaylight PDTphotodynamic therapy

Identifiers

PMID40919250
PMCPMC12413232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.